GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.

This round brings together mission-aligned leaders across industry, research, and impact investing to advance AI reporting ...

TAIPEI, TAIWAN - Media OutReach Newswire - 27 November 2025 - Responding to the rapidly growing demand for high-density, ...

Chronic respiratory illnesses continue to be a growing health challenge in India. According to recent study, around 55 million people are living with chronic obstructive pulmonary disease ...

MORTGAGE FORECLOSURE SALE. Default having been made in the payment of the indebtedness secured by that certain mortgage executed by Adam Neville, single man, originally in favor o ...